Latest News in the pharma Industry

Top Stories

Pfizer Considers $3Bn Partial IPO

Pfizer Considers $3Bn Partial IPO

21 Feb 2012

Pfizer is said to raise about $3bn this year through a part-flotation of its animal health division.

Read more 
18% Growth in Sales Accelerates Investment and Expansion Plans for Robinson Brothers and Endeavour

18% Growth in Sales Accelerates Investment and Expansion Plans for Robinson Brothers and Endeavour

20 Feb 2012

UK’s independent chemical manufacturer Robinson Brothers Limited announced a significant rise in group sales for 2011.

Read more 
Endeavour Speciality Chemicals Enters Partnership with AKL Research

Endeavour Speciality Chemicals Enters Partnership with AKL Research

20 Feb 2012

Under the agreement Endeavour will act as the sole scale-up partner for the AKL range of building blocks and chemical intermediates, many of which are commercially novel.

Read more 
Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals

Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals

20 Feb 2012

Par Pharmaceutical has completed the acquisition of India-based Edict Pharmaceuticals, a developer and manufacturer of generic pharmaceuticals with 11 ANDAs filed with the FDA.

Read more 
Evotec & IR Pharma Ink Respiratory Discovery Pact

Evotec & IR Pharma Ink Respiratory Discovery Pact

17 Feb 2012

Under the alliance, Evotec will offer fully integrated respiratory and inflammation focused drug discovery programs, from target to nomination of preclinical development candidates.

Read more 
Actavis Launches Donepezil in Eight EU Markets

Actavis Launches Donepezil in Eight EU Markets

17 Feb 2012

The conventional tablets were launched in Germany, France, Italy, Spain, the UK, Denmark, Sweden and Austria this week.

Read more 
GSK Withdraws Application for Tyverb Indication Extension

GSK Withdraws Application for Tyverb Indication Extension

17 Feb 2012

The decision to withdraw the application was based on the CHMP’s assessment that the lack of an active-controlled trial hampers the proper assessment of the benefit-risk balance in European patients in the applied indication.

Read more 
BARDA Awards Tetraphase Antibiotic Contract

BARDA Awards Tetraphase Antibiotic Contract

17 Feb 2012

The BARDA contract includes preclinical efficacy and toxicology studies, clinical studies, manufacturing, and associated regulatory activities for TP-434.

Read more 
Sigma-Aldrich Completes Acquisition of BioReliance

Sigma-Aldrich Completes Acquisition of BioReliance

17 Feb 2012

The acquisition will leverage SAFC’s industrial media presence and BioReliance’s biological testing services.

Read more 
Endeavour Speciality Chemicals Announces Novel Thiourea Line

Endeavour Speciality Chemicals Announces Novel Thiourea Line

17 Feb 2012

Endeavour Speciality Chemicals has announced the introduction of a line of commercially novel pyridinyl thioureas to be used as building blocks in the research of treatments for prion diseases.

Read more 
FDA Seeks $4.5B in 2013 Budget

FDA Seeks $4.5B in 2013 Budget

16 Feb 2012

In addition to recommending new user fees to support the review of generic drugs and biosimilars, the FDA budget also contains increased funding ($1.7bn) to improve the safety of drugs and other medical products, advance medical countermeasures and fac...

Read more 
Merck & Supera Farma Form Brazilian JV

Merck & Supera Farma Form Brazilian JV

16 Feb 2012

The new JV will market, distribute and sell a portfolio of innovative pharmaceutical and branded generic products from Merck, Cristália and Eurofarma solely in the Brazilian retail sector.

Read more